1.
Tam LTK, Hoa NTT. Comment on primary effectiveness of rituximab plus chemotherapy in treating CD 20 + non hodgkin lymphoma. JCMHCH [Internet]. 2025 Feb. 18 [cited 2026 Nov. 17];5(17):191-5. Available from: https://jcmhch.com.vn/index.php/home/article/view/1806